2003
DOI: 10.1007/s11938-003-0028-3
|View full text |Cite
|
Sign up to set email alerts
|

Current insights in Whipple’s disease

Abstract: Therapy for Whipple's disease should be continued for a minimum of 1 year, and the regimen should include an agent or agents that achieve acceptable concentrations in the central nervous system, given the likelihood of recurrence at this site. Clinical follow-up of proven cases of Whipple's disease should be conducted for a minimum of 10 years after discontinuation of therapy, given the potential for late relapses. Polymerase chain reaction analysis is preferred rather than endoscopy when evaluating for diseas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2006
2006
2022
2022

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 9 publications
0
3
0
Order By: Relevance
“…[ 16 , 21 ] Patients should be followed for at least 10 years, as many develop late recurrences that can severely injure the CNS. [ 21 ]…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…[ 16 , 21 ] Patients should be followed for at least 10 years, as many develop late recurrences that can severely injure the CNS. [ 21 ]…”
Section: Discussionmentioning
confidence: 99%
“…To clear T. whippelii from the CNS, patients need primary treatment for 2 weeks with antibiotics that attain high CSF levels (e.g., ceftriaxone or penicillin G), followed by oral cotrimoxazole for 12 months. [16,21] Patients should be followed for at least 10 years, as many develop late recurrences that can severely injure the CNS. [21] Since CNS relapses carry a poor prognosis, antibiotics should not be reduced or discontinued.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation